Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NE › OMAHA › NEBRASKA METHODIST HOSPITAL

NEBRASKA METHODIST HOSPITAL

NPI: 1427147883 · OMAHA, NE 68114 · Women's Hospital · NPI assigned 10/12/2006

$14.47M
Total Medicaid Paid
573,658
Total Claims
462,671
Beneficiaries
277
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGOESER, STEVEN (EXECUTIVE VICE PRESIDENT & COO)
NPI Enumeration Date10/12/2006

Related Entities

Other providers sharing the same authorized official: GOESER, STEVEN

ProviderCityStateTotal Paid
NEBRASKA METHODIST HOSPITAL OMAHA NE $5.35M
NEBRASKA METHODIST HOSPITAL OMAHA NE $78.24

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 69,785 $1.87M
2019 69,873 $1.83M
2020 69,608 $1.85M
2021 135,144 $3.05M
2022 145,663 $3.21M
2023 61,872 $1.66M
2024 21,713 $996K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 13,153 12,243 $1.44M
96361 Intravenous infusion, hydration; each additional hour 5,894 4,287 $1.35M
99283 Emergency department visit for the evaluation and management, moderate severity 12,193 11,356 $1.31M
74177 Computed tomography, abdomen and pelvis; with contrast material 2,998 2,831 $949K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4,289 3,159 $644K
59025 Fetal non-stress test 2,930 2,246 $460K
70450 Computed tomography, head or brain; without contrast material 2,177 2,041 $443K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 4,952 4,402 $411K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 4,919 3,079 $397K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,901 3,589 $384K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 8,962 8,508 $327K
74176 Computed tomography, abdomen and pelvis; without contrast material 938 899 $284K
80053 Comprehensive metabolic panel 46,272 40,668 $266K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3,145 2,993 $255K
76819 Fetal biophysical profile; without non-stress testing 4,898 2,512 $244K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,374 1,262 $237K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 13,576 10,480 $219K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 8,954 8,500 $217K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 908 509 $188K
84443 Thyroid stimulating hormone (TSH) 16,609 16,072 $184K
G0378 Hospital observation service, per hour 2,758 1,865 $161K
71260 Computed tomography, thorax, diagnostic; with contrast material 761 725 $150K
71275 Computed tomographic angiography, chest, with contrast material 544 509 $147K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 1,740 1,639 $144K
58661 27 24 $119K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 2,092 1,532 $114K
84439 9,405 8,945 $114K
J3490 Unclassified drugs 26,909 10,394 $99K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,814 1,125 $99K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,988 1,916 $91K
88305 Level IV - Surgical pathology, gross and microscopic examination 4,140 3,585 $88K
80061 Lipid panel 13,449 13,072 $86K
87086 Culture, bacterial; quantitative colony count, urine 11,968 11,062 $82K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3,059 2,988 $78K
88142 3,535 3,382 $75K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,929 1,850 $73K
36591 2,144 1,244 $72K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2,661 2,454 $68K
71046 Radiologic examination, chest; 2 views 2,077 1,981 $67K
80055 2,586 2,419 $67K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 29,507 25,180 $66K
87631 568 544 $66K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,014 963 $62K
84702 4,628 3,152 $60K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3,565 2,666 $60K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 8,705 7,832 $59K
J7120 Ringers lactate infusion, up to 1000 cc 6,433 5,582 $58K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 1,819 1,692 $56K
76820 1,153 627 $55K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1,672 1,617 $53K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 96 87 $53K
J7030 Infusion, normal saline solution , 1000 cc 5,555 4,555 $51K
96375 Therapeutic injection; each additional sequential IV push 7,161 5,730 $50K
87653 1,274 1,248 $49K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 7,808 6,921 $48K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,560 1,509 $47K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 257 241 $47K
80048 Basic metabolic panel (calcium, ionized) 9,413 7,976 $46K
93971 350 333 $41K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 104 101 $37K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 703 254 $36K
77063 Screening digital breast tomosynthesis, bilateral 512 507 $34K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 5,054 3,300 $34K
80050 General health panel 2,215 1,959 $33K
86141 4,320 3,861 $32K
86803 3,180 3,022 $32K
96376 3,295 1,893 $31K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,898 4,517 $30K
71045 Radiologic examination, chest; single view 4,154 3,773 $28K
71250 323 315 $27K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 91 88 $25K
86703 1,871 1,766 $24K
82607 2,095 2,043 $24K
83880 1,758 1,619 $23K
86769 622 607 $23K
76801 270 252 $23K
87081 2,977 2,921 $23K
87077 3,587 3,248 $21K
86900 2,093 1,925 $18K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 2,604 2,532 $17K
82728 1,706 1,640 $17K
76642 107 102 $16K
83550 2,538 2,444 $16K
97161 404 375 $16K
88307 331 310 $15K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 893 704 $15K
76830 Ultrasound, transvaginal 381 365 $15K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2,384 2,261 $15K
76705 Ultrasound, abdominal, real time with image documentation; limited 93 93 $14K
87186 3,309 3,082 $14K
93976 208 199 $14K
84144 788 666 $14K
76821 253 128 $13K
86780 1,159 1,127 $13K
83655 747 738 $12K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,366 1,199 $12K
84703 1,941 1,830 $12K
83540 2,635 2,538 $12K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 440 426 $11K
86850 1,152 1,037 $11K
70491 41 37 $11K
84484 4,092 3,489 $10K
J8499 Prescription drug, oral, non chemotherapeutic, nos 32,375 8,055 $10K
83690 4,298 3,900 $10K
84145 1,745 1,591 $9K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 335 323 $9K
83735 3,284 2,337 $8K
76700 Ultrasound, abdominal, real time with image documentation; complete 52 50 $8K
J1170 Injection, hydromorphone, up to 4 mg 2,716 1,943 $8K
84481 1,000 890 $8K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 55 53 $7K
84153 664 637 $7K
82570 1,723 1,472 $7K
83036 Hemoglobin; glycosylated (A1C) 1,003 966 $7K
85027 2,920 2,178 $7K
81001 6,483 5,947 $7K
36415 Collection of venous blood by venipuncture 2,549 2,196 $7K
82746 786 767 $6K
82962 5,784 3,169 $6K
88304 499 482 $6K
87634 857 826 $6K
80074 485 469 $6K
85007 2,739 1,902 $6K
77336 46 13 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 303 290 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 304 284 $5K
85379 1,718 1,624 $5K
J1756 Injection, iron sucrose, 1 mg 79 38 $5K
97597 24 12 $5K
J8501 Aprepitant, oral, 5 mg 35 31 $5K
84156 1,751 1,431 $5K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 86 27 $5K
86038 432 414 $5K
87205 1,669 1,574 $5K
99156 1,470 1,374 $4K
84146 350 330 $4K
87088 614 588 $4K
83605 1,884 1,642 $4K
85610 2,691 2,345 $4K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 407 396 $4K
82565 1,515 1,442 $4K
97530 Therapeutic activities, direct patient contact, each 15 minutes 409 208 $4K
J2270 Injection, morphine sulfate, up to 10 mg 1,871 1,390 $4K
86901 2,022 1,857 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg 5,747 4,528 $4K
87040 1,000 786 $4K
87147 624 609 $3K
81003 4,216 3,907 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 1,290 1,079 $3K
82247 532 392 $3K
45380 Colonoscopy, flexible; with biopsy, single or multiple 15 13 $3K
82784 358 307 $3K
J7050 Infusion, normal saline solution, 250 cc 3,501 2,716 $3K
90715 118 116 $3K
82533 218 181 $3K
87070 605 561 $3K
96367 129 95 $3K
83615 977 749 $3K
85651 700 634 $2K
82105 198 181 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,457 2,215 $2K
83001 202 194 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 272 257 $2K
A4217 Sterile water/saline, 500 ml 2,402 2,213 $2K
82465 388 382 $2K
80081 192 177 $2K
85730 1,197 1,107 $2K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 5,145 3,274 $2K
86787 193 184 $2K
87340 283 272 $2K
J3010 Injection, fentanyl citrate, 0.1 mg 2,314 2,168 $2K
74018 48 48 $2K
93970 12 12 $2K
82670 116 94 $2K
84403 167 159 $2K
80076 214 205 $1K
88342 194 178 $1K
99281 Emergency department visit for the evaluation and management, self-limited or minor 12 12 $1K
76813 25 24 $1K
97165 25 25 $1K
71271 14 13 $1K
82378 115 88 $1K
97535 Self-care/home management training, each 15 minutes 79 44 $1K
83516 92 88 $1K
86376 102 97 $961.90
88341 29 28 $954.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 64 60 $937.36
86431 141 134 $860.19
76000 13 13 $807.42
97116 41 27 $778.15
94799 342 205 $771.76
73630 28 28 $722.32
87529 27 27 $712.66
77065 Tomosynthesis, mammo 14 13 $705.96
82550 200 169 $645.21
86592 61 59 $636.23
77067 Screening mammography, bilateral, including computer-aided detection 542 537 $622.71
99157 765 721 $547.33
82950 93 92 $539.60
82150 109 103 $499.46
73610 39 37 $490.89
82248 116 95 $488.04
J1100 Injection, dexamethasone sodium phosphate, 1 mg 323 280 $460.03
84100 287 211 $452.60
81025 3,399 3,113 $418.61
J0690 Injection, cefazolin sodium, 500 mg 1,412 1,158 $395.94
84550 109 106 $383.19
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 69 59 $374.42
72125 Computed tomography, cervical spine; without contrast material 40 39 $317.04
73562 56 54 $271.25
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 366 238 $266.77
86762 43 42 $258.44
83970 14 13 $249.05
83002 25 25 $220.23
86800 25 25 $219.72
80143 428 387 $216.67
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 97 82 $204.10
94760 882 499 $200.76
80179 402 364 $192.24
83525 13 12 $184.40
A9585 Injection, gadobutrol, 0.1 ml 321 309 $177.84
73030 28 25 $167.01
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 695 644 $159.75
84681 13 13 $143.52
84270 17 15 $143.31
J1644 Injection, heparin sodium, per 1000 units 314 229 $137.46
82947 27 27 $132.55
J3535 Drug administered through a metered dose inhaler 134 120 $132.16
J1200 Injection, diphenhydramine hcl, up to 50 mg 560 431 $127.44
87210 99 90 $122.56
J2765 Injection, metoclopramide hcl, up to 10 mg 147 130 $117.27
J0131 Injection, acetaminophen, not otherwise specified,10 mg 1,184 1,074 $103.39
80069 13 13 $99.55
85018 47 43 $91.28
80177 14 13 $87.45
82043 21 20 $74.67
J1815 Injection, insulin, per 5 units 715 325 $73.49
88302 107 93 $71.36
73502 15 13 $66.96
86364 12 12 $58.10
86304 14 12 $52.24
80164 12 12 $47.61
82077 108 82 $42.31
J2550 Injection, promethazine hcl, up to 50 mg 339 278 $34.95
J1650 Injection, enoxaparin sodium, 10 mg 522 233 $29.48
87075 13 13 $28.82
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 140 129 $24.36
82010 12 12 $14.29
73130 13 12 $12.94
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens 153 147 $11.43
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 15 14 $11.18
J2060 Injection, lorazepam, 2 mg 384 284 $10.37
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 114 76 $9.20
J0696 Injection, ceftriaxone sodium, per 250 mg 440 323 $8.02
J2250 Injection, midazolam hydrochloride, per 1 mg 261 237 $7.16
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) 519 485 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 154 145 $0.00
A6250 Skin sealants, protectants, moisturizers, ointments, any type, any size 81 70 $0.00
93770 139 121 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 12 12 $0.00
C9113 Injection, pantoprazole sodium, per vial 63 26 $0.00
A4311 Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) 61 52 $0.00
82800 13 13 $0.00
C1758 Catheter, ureteral 15 13 $0.00
72100 14 14 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 456 406 $0.00
C1769 Guide wire 477 432 $0.00
94761 423 205 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 43 34 $0.00
82803 14 13 $0.00
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 12 12 $0.00
74022 12 12 $0.00
J3480 Injection, potassium chloride, per 2 meq 27 12 $0.00
J1790 Injection, droperidol, up to 5 mg 59 52 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 15 13 $0.00
A4364 Adhesive, liquid or equal, any type, per oz 18 15 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 14 14 $0.00